We confirmed these data and additionally show that there are no differences in expression of eIF4A2 or the helicase DDX6 between our DLBCL-derived cell line, DoHH-2, and our control disease-free B-cell line, GM01953 (Supplementary Figure S1A). Here, DDX6 is linked to diffuse large B-cell lymphoma.